5Szczepiorkowski ZM,Winters JL,Bandarenko N,et al.Guidelines on the use of therapeutic apheresis in clinical practice:evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis[J].J Clin Apher,2010,25(3):83-177.
6Schwartz J,Winters JL,Padmanabhan A,et al.Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis:the sixth special issue[J].J Clin Apher,2013,28(3):145-284.
7Belák M,Ják6 J.Indications of urgent plasma exchange and cytapheresis therapies-a review based on literature data and personal experience[J].Orv Hetil,2006,147(38):1843-1848.
8Blum W,Porcu P.Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome[J].Semin Thromb Hemost,2007,33(4):350-354.
9Chang MC,Chen TY,Tang JL,et al.Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia:no impact on early mortality and intracranial hemorrhage[J].Am J Hematol,2007,82(11):976-980.
10Porcu P,Cripe LD,Ng EW,et al.Hyperleukocytic leukemias and leukostasis.:a review of pathophysiology,clinical presentation and management[J].Leuk Lymphoma,2000,39(1-2):1-18.
